Last updated on 11 Sept 2024
Owner Info
Boston Pharmaceuticals, Inc.
55 Cambridge Parkway, Suite 401
Cambridge MA 02142, UNITED STATES OF AMERICA
Serial Number
2456059 filed on 21 Mar 2024
Correspondent
Camille M. Miller Cozen O'Connor
1650 Market Street, Suite 2800,
Philadelphia PA 19103,
UNITED STATES OF AMERICA
2456059
NA
NA
WORD
4 Oct 2023
US
Status Date | Action Taken |
---|---|
11th Sept 2024 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
10th Sept 2024 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
10th Sept 2024 | IP Right Registration Published |
10th Sept 2024 | Status change to Registered/Protected |
4th Jul 2024 | Application Accepted correspondence sent |
3rd Jul 2024 | Application Accepted correspondence sent |
3rd Jul 2024 | IP Right has been Examined |
3rd Jul 2024 | IP Right Acceptance Published |
3rd Jul 2024 | Status change to Accepted |
2th Jul 2024 | Examination Response Received |